Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hypertension × Hydrochlorothiazide × Clear all

Phase

Phase NA 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Hypertension 1

Interventions

Hydrochlorothiazide 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Amlodipine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02072330 2014-02-26

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Takeda

Phase 2/3 Completed

Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡